The U.S. Nuclear Regulatory Commission (NRC) has published the final rule and guidance on how to deal with the medical use of nuclear byproducts by providing recommendations on training and adopting common terms and definitions.
The document, published in the Federal Register (July 16, 2018, Vol. 83:136, pp. 33046-33112, offers amendments to training and experience requirements in certain sections, including how to measure molybdenum contamination.
The provision deals with modifications for the elutions of molybdenum-99 (Mo-99) /technetium-99m (Tc-99m) generators to include a mandate to notify when a generation elution exceeds permissible Mo-99, strontium-82, or strontium-85 concentrations. It also adds a new requirement for when to report failed technetium and rubidium generators.
Many revisions were recommended by the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
The NRC's final rule goes into effect on January 14, 2019.
